RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$791M
AUM Growth
-$79M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$15.7M
2 +$12.6M
3 +$12.1M
4
CAH icon
Cardinal Health
CAH
+$9.24M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.47M

Top Sells

1 +$19.8M
2 +$15.2M
3 +$14.9M
4
UNH icon
UnitedHealth
UNH
+$14.7M
5
MCK icon
McKesson
MCK
+$14.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
1
Eli Lilly
LLY
$740B
$45.1M 5.7%
57,870
+16,120
BSX icon
2
Boston Scientific
BSX
$150B
$31.8M 4.02%
296,000
-4,000
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$108B
$27.4M 3.46%
61,455
-5,295
GKOS icon
4
Glaukos
GKOS
$4.28B
$24.3M 3.07%
235,000
-35,000
ISRG icon
5
Intuitive Surgical
ISRG
$194B
$24.1M 3.05%
44,350
-7,150
THC icon
6
Tenet Healthcare
THC
$18.6B
$24M 3.04%
136,429
+9,729
DHR icon
7
Danaher
DHR
$158B
$24M 3.03%
121,452
+79,500
CVS icon
8
CVS Health
CVS
$104B
$20.4M 2.58%
295,362
+59,500
MCK icon
9
McKesson
MCK
$99.7B
$20.3M 2.57%
27,717
-19,500
NBIX icon
10
Neurocrine Biosciences
NBIX
$14.3B
$18.8M 2.37%
149,217
+59,400
GILD icon
11
Gilead Sciences
GILD
$150B
$18.6M 2.36%
168,150
-65,350
EXAS icon
12
Exact Sciences
EXAS
$12.2B
$18.6M 2.35%
350,000
-90,000
ALHC icon
13
Alignment Healthcare
ALHC
$3.47B
$18M 2.28%
1,287,284
-50,000
INSM icon
14
Insmed
INSM
$33.7B
$17.7M 2.23%
175,435
-10,065
ELV icon
15
Elevance Health
ELV
$76.1B
$17.4M 2.2%
44,650
-4,300
EHC icon
16
Encompass Health
EHC
$12.7B
$16.7M 2.11%
136,400
+99,000
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$60.7B
$16.7M 2.11%
51,197
+3,000
MDT icon
18
Medtronic
MDT
$120B
$15.6M 1.98%
179,500
-75,500
COR icon
19
Cencora
COR
$64.5B
$14.8M 1.87%
49,375
+17,000
REGN icon
20
Regeneron Pharmaceuticals
REGN
$61.3B
$14.5M 1.84%
27,700
-4,050
PODD icon
21
Insulet
PODD
$22.6B
$14.5M 1.83%
46,000
-15,000
DXCM icon
22
DexCom
DXCM
$27.6B
$13.9M 1.76%
159,500
+4,500
ABBV icon
23
AbbVie
ABBV
$403B
$12.9M 1.63%
69,375
-19,275
ALGN icon
24
Align Technology
ALGN
$9.8B
$12.6M 1.59%
66,500
+25,000
RPRX icon
25
Royalty Pharma
RPRX
$16.1B
$12.4M 1.57%
344,000
-67,000